🇺🇸 FDA
Patent

US 10925977

Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications

granted A61KA61K49/0002A61K49/06

Quick answer

US patent 10925977 (Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications) held by The Board of Regents of the University of Texas System expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K49/0002, A61K49/06, A61K51/0491, A61P